ABSTRACT
An essential aspect of stem cell culture is the successful maintenance of the undifferentiated state. Many types of stem cells are FGF2 dependent, and pluripotent stem cells are maintained by replacing FGF2-containing media daily, while tissue-specific stem cells are typically fed every 3rd day. Frequent feeding, however, results in significant variation in growth factor levels due to FGF2 instability, which limits effective maintenance due to spontaneous differentiation. We report that stabilization of FGF2 levels using controlled release PLGA microspheres improves expression of stem cell markers, increases stem cell numbers and decreases spontaneous differentiation. The controlled release FGF2 additive reduces the frequency of media changes needed to maintain stem cell cultures, so that human embryonic stem cells and induced pluripotent stem cells can be maintained successfully with biweekly feedings.
Subject(s)
Cell Culture Techniques/methods , Cell Differentiation/drug effects , Fibroblast Growth Factor 2/pharmacology , Stem Cells/cytology , Animals , Cells, Cultured , Cells, Immobilized/cytology , Cells, Immobilized/drug effects , Culture Media/pharmacology , Embryonic Stem Cells/cytology , Embryonic Stem Cells/drug effects , Embryonic Stem Cells/enzymology , Enzyme Activation/drug effects , Humans , Induced Pluripotent Stem Cells/cytology , Induced Pluripotent Stem Cells/drug effects , Induced Pluripotent Stem Cells/enzymology , Lactic Acid , MAP Kinase Signaling System/drug effects , Mice , Microspheres , Mitogen-Activated Protein Kinases/metabolism , Neural Stem Cells/cytology , Neural Stem Cells/drug effects , Neural Stem Cells/enzymology , Polyglycolic Acid , Polylactic Acid-Polyglycolic Acid Copolymer , Stem Cells/drug effects , Stem Cells/enzymologyABSTRACT
Recently lactose mediated auto-induction in Escherichia coli has gained a lot of interest because higher protein titer could be achieved without the need to monitor growth and add inducer at the proper time. In this study a high level therapeutic protein production by auto-induction was observed in E. coli BL21 using either T7 or tac promoters in the modified Luria Bertani (mLB) medium containing soy peptone instead of tryptone in Luria Bertani (LB) medium. Based on medium analysis and spiking experiments it was found that 0.4 mM galactose from the soy peptone caused the auto-induction. E. coli cultures induced by galactose can saturate at considerably higher density than cultures induced by IPTG. Galactose is not consumed by E. coli BL21. Finally it has been demonstrated that auto-induction can be effectively used in fed-batch fermentation for the industrial production of a therapeutic protein. The principle of galactose mediated auto-induction should be able to apply to high throughput microplates, shake flasks and fed-batch fermentors for clone screening and therapeutic protein expression in E. coli gal(-) strains such as most commonly used BL21.
Subject(s)
Bioreactors/microbiology , Escherichia coli/genetics , Galactose/pharmacology , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , Transcriptional Activation/drug effects , Biomass , Culture Media/chemistry , Escherichia coli/metabolism , Fermentation , Recombinant Proteins/metabolismABSTRACT
After spinal cord injury (SCI), loss of cells and damage to ascending and descending tracts can result in paralysis. Current treatments for SCI are based on patient stabilization, and much-needed regenerative therapies are still under development. To activate and instruct stem and progenitor cells or injured tissue to aid SCI repair, it is important to modify the injury environment for a protracted period, to allow time for cell activation, proliferation and appropriate fate differentiation. Shh plays a critical role in spinal cord formation, being involved in multiple processes: it promotes production of motor neurons and oligodendrocytes from ventral cord progenitor cells and serves as an axon guidance molecule. Hence Shh is a candidate pleiotropic beneficial environmental factor for spinal cord regeneration. Here we show that administration of biodegradable microspheres that provide sustained, controlled delivery of Shh resulted in significant functional improvement in two different mouse models of SCI: contusion and dorsal hemioversection. The mechanism is multifactorial, involving increased proliferation of endogenous NG2+ oligodendrocyte lineage cells, decreased astrocytic scar formation and increased sprouting and growth of corticospinal (CST) and raphespinal tract (RST) fibers. Thus, long-term administration of Shh is a potential valuable therapeutic intervention for SCI.
Subject(s)
Hedgehog Proteins/pharmacology , Implants, Experimental , Microspheres , Recovery of Function/drug effects , Spinal Cord Injuries/physiopathology , Animals , Astrocytes/drug effects , Astrocytes/pathology , Biodegradation, Environmental/drug effects , Cell Proliferation/drug effects , Delayed-Action Preparations/pharmacology , Disease Models, Animal , Gene Expression Regulation/drug effects , Lactic Acid/pharmacology , Mice , Mice, Inbred C57BL , Polyglycolic Acid/pharmacology , Polylactic Acid-Polyglycolic Acid Copolymer , Spinal Cord Injuries/pathology , Stem Cells/drug effectsABSTRACT
Intracellular delivery of specific proteins and peptides may be used to influence signaling pathways and manipulate cell function, including stem cell fate. Herein, we describe the delivery of proteins attached to hydrophobically modified 15-nm silica nanoparticles to manipulate specifically targeted cell signaling proteins. We designed a chimeric protein, GFP-FRATtide, wherein GFP acts as a biomarker for fluorescence detection, and FRATtide binds to and blocks the active site of glycogen synthase kinase-3ß (GSK-3ß) - a protein kinase involved in Wnt signaling. The SiNP-chimeric protein conjugates were efficiently delivered to the cytosol of human embryonic kidney cells and rat neural stem cells, presumably via endocytosis. This uptake impacted the Wnt signaling cascade, resulting in an elevation of ß-catenin levels due to GSK-3ß inhibition. Accumulation of ß-catenin led to increased transcription of Wnt target genes, such as c-MYC, which instruct the cell to actively proliferate and remain in an undifferentiated state. The results presented here suggest that functional proteins can be delivered intracellularly in vitro using nanoparticles and used to target key signaling proteins and regulate cell signaling pathways. This ability is critical for the design of in vitro screens for gain/loss of pathway function, and may also prove to be useful for in vivo delivery applications.
Subject(s)
Drug Delivery Systems/methods , Intracellular Space/metabolism , Nanoparticles/chemistry , Neural Stem Cells/metabolism , Recombinant Fusion Proteins/metabolism , Signal Transduction , Animals , Endocytosis , Fluorescent Antibody Technique , Glycogen Synthase Kinase 3/antagonists & inhibitors , Glycogen Synthase Kinase 3 beta , Green Fluorescent Proteins/metabolism , HEK293 Cells , High-Throughput Screening Assays , Humans , Peptides/metabolism , Protein Engineering , Proto-Oncogene Proteins c-myc/metabolism , Rats , Silicon Dioxide/chemistry , Transfection , beta Catenin/metabolismABSTRACT
Despite recent advances in nanomaterial-based delivery systems, their applicability as carriers of cargo, especially proteins for targeting cellular components and manipulating cell function, is not well-understood. Herein, we demonstrate the ability of hydrophobic silica nanoparticles to deliver proteins, including enzymes and antibodies, to a diverse set of mammalian cells, including human cancer cells and rat stem cells, while preserving the activity of the biomolecule post-delivery. Specifically, we have explored the delivery and cytosolic activity of hydrophobically functionalized silica nanoparticle-protein conjugates in a human breast cancer cell line (MCF-7) and rat neural stem cells (NSCs) and elucidated the mechanism of cytosolic transport. Importantly, the proteins were delivered to the cytosol without extended entrapment in the endosomes, which facilitated the retention of biological activity of the delivered proteins. As a result, delivery of ribonuclease A (RNase A) and the antibody to phospho-Akt (pAkt) resulted in the initiation of cell death. Delivery of control protein conjugates (e.g., those containing green fluorescent protein or goat antirabbit IgG) resulted in minimal cell death, indicating that the carrier-mediated toxicity was low. The results presented here provide insight into the design of nanomaterials as protein carriers that enable control of cell function.
Subject(s)
Cytoplasm/metabolism , Drug Carriers/chemistry , Drug Carriers/metabolism , Nanoparticles , Proteins/metabolism , Animals , Cattle , Cell Differentiation , Cell Line, Tumor , Cell Survival/drug effects , Drug Carriers/toxicity , Endosomes/metabolism , Female , Flow Cytometry , Humans , Hydrophobic and Hydrophilic Interactions , Immobilized Proteins/chemistry , Immobilized Proteins/metabolism , Proteins/chemistry , Rats , Signal Transduction , Silicon Dioxide/chemistry , Silicon Dioxide/metabolism , Stem Cells/cytology , Stem Cells/metabolismABSTRACT
There has been an increasing interest in understanding how the mechanical properties of the microenvironment influence stem cell fate. We describe studies of the proliferation and differentiation of neural stem cells (NSCs) encapsulated within three-dimensional scaffolds--alginate hydrogels--whose elastic moduli were varied over two orders of magnitude. The rate of proliferation of neural stem cells decreased with increase in the modulus of the hydrogels. Moreover, we observed the greatest enhancement in expression of the neuronal marker beta-tubulin III within the softest hydrogels, which had an elastic modulus comparable to that of brain tissues. To our knowledge, this work represents the first demonstration of the influence of modulus on NSC differentiation in three-dimensional scaffolds. Three-dimensional scaffolds that control stem cell fate would be broadly useful for applications in regenerative medicine and tissue engineering.
Subject(s)
Cell Differentiation , Elastic Modulus , Hydrogel, Polyethylene Glycol Dimethacrylate/chemistry , Neurons/cytology , Stem Cells/cytology , Alginates/chemistry , Animals , Cell Proliferation , Female , Glucuronic Acid/chemistry , Hexuronic Acids/chemistry , Intermediate Filament Proteins/metabolism , Microscopy, Confocal , Nerve Tissue Proteins/metabolism , Nestin , Rats , Rats, Inbred F344 , Reverse Transcriptase Polymerase Chain Reaction , Tubulin/genetics , Tubulin/metabolismABSTRACT
We describe the parallel synthesis and in vitro evaluation of a cationic polymer library for the discovery of nonviral gene delivery vectors. The library was synthesized based on the ring-opening polymerization reaction between epoxide groups of diglycidyl ethers and the amines of (poly)amines. Parallel screening of soluble library constituents led to the identification of lead polymers with high DNA-binding efficacies. Transfection efficacies of lead polymers were evaluated using PC3-PSMA human prostate cancer cells and murine osteoblasts in the absence and presence of serum. In vitro experiments resulted in the identification of a candidate polymer that demonstrated significantly higher transfection efficacies and lower cytotoxicities than poly(ethyleneimine) (pEI), the current standard for polymeric transfection agents. In addition, polymers that demonstrated moderately higher and comparable transfection efficacies with respect to pEI were also identified. Our results demonstrate that high-throughput synthesis and screening of polymers is a powerful approach for the identification of novel nonviral gene delivery agents.
Subject(s)
Polymers/chemical synthesis , Transgenes/genetics , Cations/chemistry , Cell Line, Tumor , Cell Survival/drug effects , Combinatorial Chemistry Techniques , DNA/genetics , Humans , Molecular Structure , Polymers/chemistry , Polymers/toxicityABSTRACT
We describe a method for creating alginate hydrogels with adjustable degradation rates that can be used as scaffolds for stem cells. Alginate hydrogels have been widely tested as three-dimensional constructs for cell culture, cell carriers for implantation, and in tissue regeneration applications; however, alginate hydrogel implants can take months to disappear from implantation sites because mammals do not produce endogenous alginases. By incorporating poly(lactide-co-glycolide) (PLGA) microspheres loaded with alginate lyase into alginate hydrogels, we demonstrate that alginate hydrogels can be enzymatically degraded in a controlled and tunable fashion. We demonstrate that neural progenitor cells (NPCs) can be cultured and expanded in vitro in this degradable alginate hydrogel system. Moreover, we observe a significant increase in the expansion rate of NPCs cultured in degrading alginate hydrogels versus NPCs cultured in standard, i.e. non-degrading, alginate hydrogels. Degradable alginate hydrogels encapsulating stem cells may be widely applied to develop novel therapies for tissue regeneration.